breast cancer

How Professor Nagi El Saghir Changed the Language of Cancer in the Middle East and Helped Redefine Global Oncology The airport in Beirut looked very different in 1971. Families walked all the way to the aircraft. Parents accompanied their children…

CAM use linked to higher mortality in breast cancer patients A cohort study of women with breast cancer has shown that use of complementary and alternative medicine (CAM) in association with traditional therapies was associated with higher mortality compared with…

In a breast clinic in Africa, fear often arrives before diagnosis. Women arrive convinced they have cancer. Some have discovered a lump only days earlier; others have lived with symptoms for years. Many have never been taught breast awareness. Others…

Timing of radiotherapy administration may significantly influence treatment efficacy in breast and prostate cancer. A Spanish study, published in Nature Communications, demonstrates that circadian oscillation of Cryptochrome 1 (CRY1) modulates DNA double-strand break (DSB) repair, making radiotherapy more effective in…

“Life is often a sequence of chance events, and many times we are called to rewrite our own narrative.” For Dr Lazaros Papadopoulos, that idea is not abstract. It is the thread that connects a childhood shaped by admiration for…

Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…

Prof. Martine Piccart grew up in a house where medicine was part of the air. Her father, a gynecologist, treated patients at home. “I admired him deeply,” she says. “He helped people. I saw that up close. It left a…

What does it take to change the odds in cancer care? Innovation? Yes. But also: persistence. Collaboration. The refusal to accept that some lives matter less because of where they’re born. In this issue of CancerWorld, we focus not just…

April 2025 marked a significant month in oncology, with notable advancements in cancer treatment and research. Here’s a summary of the most compelling studies and recent breakthroughs that caught our eye this month. Popular CT scans could account for 5%…

It’s long been clear that, in most patients with metastatic HER-positive breast cancer, adding effective HER2 blockade to cytotoxics can result in very prolonged responses. Janet Fricker reports on the prospective trials building evidence on whether – and in whom…